Analytical Investigation of the Profile of Human Chorionic Gonadotropin in Highly Purified Human Menopausal Gonadotrophin Preparations

Angela Capolupo, Sofia Petrocchi, Maura Melchiorre, Kim Jonas, Thomas D'Hooghe, Aylin Hanyaloglu, Sesh Sunkara, Angelo Palmese, Beste Ozgumus, Angela Amoresano, Gabriella Angiuoni, Susana Montenegro, Patrizia Simone, Monica Lispi

Research output: Contribution to journalArticlepeer-review

Abstract

Highly purified human menopausal gonadotropin (HP-hMG [Menopur ®, Ferring Pharmaceuticals, Saint-Prex, Switzerland]) contains a 1:1 ratio of follicle-stimulating hormone (FSH) and luteinizing hormone (LH). This analysis aimed to assess gonadotropin (FSH, LH and hCG) abundance in HP-hMG and clarify the source of hCG by assessing the presence of sulfated glycans, which are diagnostic for pituitary hCG forms due to their distinct glycosylation patterns. Additionally, the purity of each sample, their specific components, and their oxidation levels were assessed. HP-hMG samples (three of Menopur ® and two of Menogon ® Ferring Pharmaceuticals, Saint-Prex, Switzerland) were included in the current analyses. Brevactid ® (urinary hCG; Ferring Pharmaceuticals, Saint-Prex, Switzerland) and Ovidrel ® (recombinant hCG; Merck KGaA, Darmstadt, Germany) were used as control samples. Glycopeptide mapping and analysis of impurities were carried out by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Oxidation was assessed through reducing peptide mapping using LC-MS/MS. The FSH and LH in the HP-hMG samples showed sulfated glycans, while no signals of sulfated glycopeptides were detected on any site of the beta subunit of hCG. HP-hMG test samples presented the same hCG glycan distribution as the control sample (placental hCG, Brevactid ®) extracted from the urine of pregnant women, suggesting a non-pituitary source of hCG. Protein impurities were estimated to constitute approximately 20-30% of the entire HP-hMG protein content in the test samples. More than 200 non-gonadotropin proteins were identified in the HP-hMG test samples, of which several were involved in embryonic development or pregnancy. The alpha subunit of the tested samples was strongly oxidized, with a relative abundance of 20% of the total gonadotropin content. Without taking into account all the protein impurities, the beta subunit of LH was detected only in traces (0.9-1.2%) in all tested HP-HMG samples, confirming the data obtained by intact molecule analysis, while high levels of beta hCG (18-47%) were observed. Advanced molecular analysis of HP-hMG indicates a primarily placental origin of hCG, as evidenced by the absence of hCG sulfated glycans and the predominance of placental non-sulfated hCG in LH activity. The analysis revealed 20-30% of protein impurities and a significant presence of oxidized forms in the HP-hMG samples. These findings are critical for understanding the quality, safety, and clinical profile of HP-hMG.

Original languageEnglish
Article number9405
JournalInternational Journal of Molecular Sciences
Volume25
Issue number17
DOIs
Publication statusPublished - 29 Aug 2024

Keywords

  • Female
  • Humans
  • Chorionic Gonadotropin/analysis
  • Chromatography, Liquid/methods
  • Follicle Stimulating Hormone/urine
  • Glycopeptides/analysis
  • Glycosylation
  • Luteinizing Hormone/urine
  • Menotropins/urine
  • Oxidation-Reduction
  • Polysaccharides/analysis
  • Tandem Mass Spectrometry/methods
  • Menopause
  • Postmenopause

Fingerprint

Dive into the research topics of 'Analytical Investigation of the Profile of Human Chorionic Gonadotropin in Highly Purified Human Menopausal Gonadotrophin Preparations'. Together they form a unique fingerprint.

Cite this